{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T14:14:43Z","timestamp":1785766483690,"version":"3.56.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Ministries of Education, Culture, Sports, Science and Technology (K.K.)"},{"name":"Precursory Research for Embryonic Science and Technology (K.K.)"},{"name":"Ministry of Health, Labour and Welfare of Japan"},{"name":"Japan Society for the Promotion of Science Fellows (N.S.)"},{"name":"Japan Tobacco Inc."}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jdsjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.jdermsci.2016.09.007","type":"journal-article","created":{"date-parts":[[2016,9,14]],"date-time":"2016-09-14T16:04:46Z","timestamp":1473869086000},"page":"258-265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["JAK inhibitor JTE-052 regulates contact hypersensitivity by downmodulating T cell activation and differentiation"],"prefix":"10.1016","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3936-6926","authenticated-orcid":false,"given":"Wataru","family":"Amano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeko","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuo","family":"Tanimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mutsuyoshi","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Miyachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0773-0554","authenticated-orcid":false,"given":"Kenji","family":"Kabashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdermsci.2016.09.007_bib0005","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/jid.2012.284","article-title":"Update of immune events in the murine contact hypersensitivity model: toward the understanding of allergic contact dermatitis","volume":"133","author":"Honda","year":"2013","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.09.007_bib0010","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nri3150","article-title":"Early immune events in the induction of allergic contact dermatitis","volume":"12","author":"Kaplan","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jdermsci.2016.09.007_bib0015","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1046\/j.1365-2230.2002.00997.x","article-title":"Irritant dermatitis, irritancy and its role in allergic contact dermatitis","volume":"27","author":"Smith","year":"2002","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.09.007_bib0020","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.coi.2012.08.003","article-title":"Allergic contact dermatitis: xenoinflammation of the skin","volume":"24","author":"Martin","year":"2012","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jdermsci.2016.09.007_bib0025","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1146\/annurev.immunol.18.1.767","article-title":"Immunobiology of dendritic cells","volume":"18","author":"Banchereau","year":"2000","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jdermsci.2016.09.007_bib0030","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1038\/jid.2008.5","article-title":"Cutaneous hypersensitivities to hapten are controlled by IFN-gamma-upregulated keratinocyte Th1 chemokines and IFN-gamma-downregulated langerhans cell Th2 chemokines","volume":"128","author":"Mori","year":"2008","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.09.007_bib0035","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/nri1226","article-title":"Regulation of JAK-STAT signalling in the immune system","volume":"3","author":"Shuai","year":"2003","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jdermsci.2016.09.007_bib0040","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.immuni.2012.03.014","article-title":"JAK and STAT signaling molecules in immunoregulation and immune-mediated disease","volume":"36","author":"O'Shea","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.jdermsci.2016.09.007_bib0045","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2174\/1874312901206010232","article-title":"JAK kinases in health and disease: an update","volume":"6","author":"Laurence","year":"2012","journal-title":"Open Rheumatol. J."},{"key":"10.1016\/j.jdermsci.2016.09.007_bib0050","doi-asserted-by":"crossref","first-page":"4234","DOI":"10.4049\/jimmunol.1003668","article-title":"Modulation of innate and adaptive immune responses by tofacitinib (CP-690,550)","volume":"186","author":"Ghoreschi","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2016.09.007_bib0055","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1471-2172-12-51","article-title":"Inhibitory effects of the JAK inhibitor CP690,550 on human CD4(+) T lymphocyte cytokine production","volume":"12","author":"Migita","year":"2011","journal-title":"BMC Immunol."},{"key":"10.1016\/j.jdermsci.2016.09.007_bib0060","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1182\/blood-2013-03-484642","article-title":"The JAK-inhibitor ruxolitinib impairs dendritic cell function in vitro and in vivo","volume":"122","author":"Heine","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jdermsci.2016.09.007_bib0065","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1038\/jid.2011.140","article-title":"Preclinical evaluation of local JAK1 and JAK2 inhibition in cutaneous inflammation","volume":"131","author":"Fridman","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.09.007_bib0070","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00011-014-0782-9","article-title":"Pharmacological properties of JTE-052: a novel potent JAK inhibitor that suppresses various inflammatory responses in vitro and in vivo","volume":"64","author":"Tanimoto","year":"2015","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.jdermsci.2016.09.007_bib0075","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jaci.2015.03.051","article-title":"The Janus kinase inhibitor JTE-052 improves skin barrier function through suppressing signal transducer and activator of transcription 3 signaling","volume":"136","author":"Amano","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jdermsci.2016.09.007_bib0080","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.4049\/jimmunol.0903260","article-title":"Prostaglandin I2-IP signaling promotes Th1 differentiation in a mouse model of contact hypersensitivity","volume":"184","author":"Nakajima","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2016.09.007_bib0085","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jaci.2014.02.026","article-title":"Basophils regulate the recruitment of eosinophils in a murine model of irritant contact dermatitis","volume":"134","author":"Nakashima","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jdermsci.2016.09.007_bib0090","doi-asserted-by":"crossref","first-page":"e55487","DOI":"10.1371\/journal.pone.0055487","article-title":"Novel mechanism of inhibition of dendritic cells maturation by mesenchymal stem cells via interleukin-10 and the JAK1\/STAT3 signaling pathway","volume":"8","author":"Liu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jdermsci.2016.09.007_bib0095","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000347184","article-title":"Effects of the Janus kinase inhibitor CP-690550 (tofacitinib) in a rat model of oxazolone-induced chronic dermatitis","volume":"91","author":"Fujii","year":"2013","journal-title":"Pharmacol"},{"key":"10.1016\/j.jdermsci.2016.09.007_bib0100","doi-asserted-by":"crossref","first-page":"e9593","DOI":"10.1371\/journal.pone.0009593","article-title":"Loss of Jak2 selectively suppresses DC-mediated innate immune response and protects mice from lethal dose of LPS-induced septic shock","volume":"5","author":"Zhong","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jdermsci.2016.09.007_bib0105","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1038\/jid.2011.198","article-title":"Skin as a peripheral lymphoid organ: revisiting the concept of skin-associated lymphoid tissues","volume":"131","author":"Egawa","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.09.007_bib0110","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/exd.12716","article-title":"Proposal of inducible skin-associated lymphoid tissue (iSALT)","volume":"24","author":"Ono","year":"2015","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.09.007_bib0115","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/ni.2992","article-title":"Perivascular leukocyte clusters are essential for efficient activation of effector T cells in the skin","volume":"15","author":"Natsuaki","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jdermsci.2016.09.007_bib0120","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.4049\/jimmunol.168.7.3195","article-title":"IFN-gamma-inducible protein 10 (IP-10; CXCL10)-deficient mice reveal a role for IP-10 in effector T cell generation and trafficking","volume":"168","author":"Dufour","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2016.09.007_bib0125","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.4049\/jimmunol.168.6.3079","article-title":"Skin inflammation during contact hypersensitivity is mediated by early recruitment of CD8+ T cytotoxic 1 cells inducing keratinocyte apoptosis","volume":"168","author":"Akiba","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2016.09.007_bib0130","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1084\/jem.167.4.1323","article-title":"Adhesion of T lymphoblasts to epidermal keratinocytes is regulated by interferon gamma and is mediated by intercellular adhesion molecule 1 (ICAM-1)","volume":"167","author":"Dustin","year":"1988","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jdermsci.2016.09.007_bib0135","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/med.10001","article-title":"Inhibition of LFA-1\/ICAM-1 and VLA-4\/VCAM-1 as a therapeutic approach to inflammation and autoimmune diseases","volume":"22","author":"Yusuf-Makagiansar","year":"2002","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.jdermsci.2016.09.007_bib0140","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.nbd.2014.03.010","article-title":"Inhibition of junctional adhesion molecule-A\/LFA interaction attenuates leukocyte trafficking and inflammation in brain ischemia\/reperfusion injury","volume":"67","author":"Sladojevic","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jdermsci.2016.09.007_bib0145","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.4049\/jimmunol.0804063","article-title":"JAK3 inhibition significantly attenuates psoriasiform skin inflammation in CD18 mutant PL\/J mice","volume":"183","author":"Chang","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2016.09.007_bib0150","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1111\/bjd.14018","article-title":"Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trials","volume":"173","author":"Papp","year":"2015","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.09.007_bib0155","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nm.3645","article-title":"Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition","volume":"20","author":"Xing","year":"2014","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.jdermsci.2016.09.007_bib0160","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jdermsci.2013.02.001","article-title":"New concept of the pathogenesis of atopic dermatitis: interplay among the barrier, allergy, and pruritus as a trinity","volume":"70","author":"Kabashima","year":"2013","journal-title":"J. Dermatol. Sci."},{"issue":"2","key":"10.1016\/j.jdermsci.2016.09.007_bib0165","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jdermsci.2014.08.010","article-title":"Classification of inflammatory skin diseases: a proposal based on the disorders of the three-layered defense systems, barrier, innate immunity and acquired immunity","volume":"76","author":"Dainichi","year":"2014","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.jdermsci.2016.09.007_bib0170","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jaci.2016.06.002","article-title":"Multifactorial skin barrier deficiency and atopic dermatitis: essential topics to prevent the atopic march","volume":"138","author":"Egawa","year":"2016","journal-title":"J. Allergy Clin. Immunol."}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181116307691?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181116307691?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T09:55:00Z","timestamp":1568368500000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181116307691"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0923181116307691"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2016.09.007","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"JAK inhibitor JTE-052 regulates contact hypersensitivity by downmodulating T cell activation and differentiation","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2016.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}